Description

6α-[(R)-2-[2-[(Imino-4-Pyridylmethyl)Amino]Acetylamino]-2-Phenylacetylamino]Penicillanic Acid Sodium Salt is a high-purity, semi-synthetic penicillin derivative designed for advanced pharmaceutical research and development. This compound is critical for its role as a key intermediate in the synthesis of novel β-lactam antibiotics, offering a sophisticated chemical scaffold for targeting resistant bacterial strains. It is primarily utilized by pharmaceutical manufacturers and research institutions focused on developing next-generation antibacterial agents and studying structure-activity relationships.

Application

• Pharmaceutical Intermediate: Serves as a crucial building block in the synthesis of advanced-generation penicillin and cephalosporin antibiotics.
• Antibacterial Research: Used in R&D laboratories for studying β-lactamase inhibition and developing new antibacterial compounds against drug-resistant bacteria.
• Active Pharmaceutical Ingredient (API) Synthesis: Employed in the production pathway for specific, potent β-lactam antibiotic APIs.
• Biochemical Studies: Utilized as a reference standard or probe in enzymatic studies related to bacterial cell wall synthesis and inhibition mechanisms.
• Process Chemistry Development: Applied in scaling up and optimizing synthetic routes for complex antibiotic molecules in pilot plants.

Basic Information

Product Name	6α-[(R)-2-[2-[(Imino-4-Pyridylmethyl)Amino]Acetylamino]-2-Phenylacetylamino]Penicillanic Acid Sodium Salt
CAS No.	55162-26-0
Molecular Formula	C24H25N6NaO5S
Molecular Weight	532.55 g/mol
Synonyms	6-[(R)-2-[[2-[(Imino-4-pyridylmethyl)amino]acetyl]amino]-2-phenylacetamido]penicillanic acid sodium salt; Sodium 6-[(R)-2-[[2-[(Imino-4-pyridylmethyl)amino]acetyl]amino]-2-phenylacetamido]penicillanate; BL-P 2013 sodium salt; (2S,5R,6R)-6-[[(2R)-2-[[2-[(Imino-4-pyridylmethyl)amino]acetyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid sodium salt; Ampicillin derivative sodium salt; 4-Pyridinecarboximidamide, N-[2-[[(2R)-2-[[(2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]amino]-2-phenylacetyl]amino]ethyl]-, sodium salt (1:1)
EINECS	Contact for details

Quality Control

Our 6α-[(R)-2-[2-[(Imino-4-Pyridylmethyl)Amino]Acetylamino]-2-Phenylacetylamino]Penicillanic Acid Sodium Salt is manufactured under strict quality systems suitable for pharmaceutical research. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via IR and NMR spectroscopy. A comprehensive Certificate of Analysis (COA) detailing assay, impurity profile, and residual solvents is provided to ensure traceability and compliance with your research or development protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	≤ 20 ppm
Bacterial Endotoxins	< 0.25 EU/mg (if applicable)

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.